These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 12122518)

  • 1. Clinical implications of antibiotic-induced endotoxin release in septic shock.
    Lepper PM; Held TK; Schneider EM; Bölke E; Gerlach H; Trautmann M
    Intensive Care Med; 2002 Jul; 28(7):824-33. PubMed ID: 12122518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic-mediated release of endotoxin and the pathogenesis of gram-negative sepsis.
    Morrison DC
    Prog Clin Biol Res; 1998; 397():199-207. PubMed ID: 9575560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for antibiotic-mediated endotoxin release as a contributing factor to lethality in experimental gram-negative sepsis.
    Morrison DC; Bucklin SE
    Scand J Infect Dis Suppl; 1996; 101():3-8. PubMed ID: 9060044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotics, cytokines, and endotoxin: a complex and evolving relationship in gram-negative sepsis.
    Horn DL; Opal SM; Lomastro E
    Scand J Infect Dis Suppl; 1996; 101():9-13. PubMed ID: 9060045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic therapy in septic shock.
    Roach AC
    Crit Care Nurs Clin North Am; 1990 Jun; 2(2):179-86. PubMed ID: 2192726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bacterial endotoxins and their effects].
    Bertók L
    Orv Hetil; 1998 Aug; 139(33):1947-53. PubMed ID: 9734211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.
    Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; Orlando F; Silvestri C; Bozzi A; Di Giulio A; Luzi C; Mangoni ML; Barra D; Saba V; Scalise G; Rinaldi AC
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2478-86. PubMed ID: 16801429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic induced endotoxin release and clinical sepsis: a review.
    Holzheimer RG
    J Chemother; 2001 Nov; 13 Spec No 1(1):159-72. PubMed ID: 11936361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release.
    Vianna RC; Gomes RN; Bozza FA; Amâncio RT; Bozza PT; David CM; Castro-Faria-Neto HC
    Shock; 2004 Feb; 21(2):115-20. PubMed ID: 14752283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New criteria for selecting the proper antimicrobial chemotherapy for severe sepsis and septic shock.
    Periti P; Mazzei T
    Int J Antimicrob Agents; 1999 Jul; 12(2):97-105. PubMed ID: 10418753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sepsis and septic shock.
    Zanetti G; Baumgartner JD; Glauser MP
    Schweiz Med Wochenschr; 1997 Mar; 127(12):489-99. PubMed ID: 9106949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endotoxin release after antibiotic treatment and its potential pathogenetic role in coagulative disorders of patients with gram-negative sepsis.
    Miragliotta G
    J Chemother; 1991 Jan; 3 Suppl 1():69-72. PubMed ID: 12041790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentration-dependency of beta-lactam-induced filament formation in Gram-negative bacteria.
    Buijs J; Dofferhoff AS; Mouton JW; Wagenvoort JH; van der Meer JW
    Clin Microbiol Infect; 2008 Apr; 14(4):344-9. PubMed ID: 18261128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic interventions aimed at preventing the biologic effects of endotoxin.
    Sable CA; Wispelwey B
    Infect Dis Clin North Am; 1991 Dec; 5(4):883-98. PubMed ID: 1783774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia.
    Gruson D; Hilbert G; Vargas F; Valentino R; Bui N; Pereyre S; Bebear C; Bebear CM; Gbikpi-Benissan G
    Crit Care Med; 2003 Jul; 31(7):1908-14. PubMed ID: 12847382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
    Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
    J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: an in-vitro and in-vivo study.
    Dofferhoff AS; Nijland JH; de Vries-Hospers HG; Mulder PO; Weits J; Bom VJ
    Scand J Infect Dis; 1991; 23(6):745-54. PubMed ID: 1815338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing doses of pentoxifylline as a continuous infusion in canine septic shock.
    Quezado ZM; Hoffman WD; Banks SM; Danner RL; Eichacker PQ; Susla GM; Natanson C
    J Pharmacol Exp Ther; 1999 Jan; 288(1):107-13. PubMed ID: 9862760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotics and endotoxic shock.
    McCabe WR
    Bull N Y Acad Med; 1975 Oct; 51(9):1084-95. PubMed ID: 1058731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the pathogenesis and therapy of sepsis and septic shock.
    Llewelyn M; Cohen J
    Curr Clin Top Infect Dis; 2001; 21():148-71. PubMed ID: 11572150
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.